Key facts
- Glenview Capital Management is a hedge fund based in New York, United States with 1 tracked portfolio company.
- Notable positions include Quanta Dialysis Technologies.
- The team roster lists 1 person.
- Glenview Capital Management reports $6.3B in regulatory assets under management across 5 private funds, per its SEC Form ADV (2026-03).
About Glenview Capital Management
57685-78P
Registered with the SEC
Form ADV · 2026-03 · CRD 137640- Regulatory AUM
- $6.3B
- Private fund assets
- $6.4B
- Private funds
- 5 · 5 hedge
- Staff
- 49
- Registered office
- NEW YORK, NY
- SEC status
- Approved
Reports custody of client assets.
Source: SEC Investment Adviser Public Disclosure, Form ADV (registered as GLENVIEW CAPITAL MANAGEMENT, LLC).
Free account
See more of the book
- ·Watchlist + alerts for Glenview Capital Management's activity
Create free account
No card required
Portfolio
1 companies · priced for members| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Quanta Dialysis Technologies | — | ▮ | ▮ | ▮ |
All 1 companies — valuations, dates and lead flags are a member feature | ||||
Team
1 people on record — 1 with verified contacts
Partners, principals, and the people who answer a pitch. Pro members reveal contacts with credits.
Frequently asked
- What companies does Glenview Capital Management invest in?
- Glenview Capital Management has 1 recorded portfolio companies, including Quanta Dialysis Technologies.